COPD Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are able to sign an informed consent form agreeing to take part in the study.
• People who are able to complete a specific breathing test (measuring how much air can be forced out of the lungs in one second) that meets recognised international standards.
• People who are able and willing to follow the study requirements, including being able to read, write, and understand the language used in the study questionnaires.
• People who are already taking part in other non-treatment research studies may still be considered for this trial.

Who may not be able to join:

• People who have had a problem with alcohol or drug misuse in the past year, if the responsible doctor believes this would make participation unsafe.
• People who are not able to think clearly or make decisions at the time of signing the consent form.
• People who have unusual results from vital sign checks, heart tests (ECG), or blood/lab tests at the screening visit that the investigator believes could affect the study or the person's safety.
• People who currently have a diagnosis of asthma.
• People who have a significant lung disease beyond what is being studied (confirm with trial site).
• People who have had a flare-up of their COPD in the two weeks before enrolling or during the screening period.
• People who have had most or all of a lung surgically removed (removal of a single lobe or smaller section may be acceptable); or who have had a procedure to reduce lung size in the six months before enrolling; or who are expected to need such a procedure during the study.
• People who have unstable medical conditions (confirm with trial site for specific details).
• People who currently have, or have had, cancer in the past five years — with limited exceptions for certain treated skin cancers or cervical changes treated successfully more than one year before enrolling. People with suspected or undefined growths are also excluded.
• People who have a terminal illness, organ failure, or who are otherwise considered by the study team to be unsuitable for participation.
• People who have received a biologic medicine — whether an approved treatment or an experimental one — within the past three months or within five half-lives of the medicine before the first study visit, whichever period is longer.
• People who are pregnant.

Important: Always verify eligibility with the trial site directly before applying.